Home Stock

Stock Research: DarioHealth

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

DarioHealth

NAQ:DRIO US23725P2092
29
  • Value
    58
  • Growth
    63
  • Safety
    Safety
    65
  • Combined
    35
  • Sentiment
    17
  • 360° View
    360° View
    29
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

DarioHealth Corp. is a global digital therapeutics company delivering personalized, data-driven interventions. It operates in digital health, offering solutions for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health, and sells products like the Dario Blood Glucose Monitoring Starter Kit and Dario Blood Pressure Monitoring System. In the last fiscal year, the company had a market cap of $31 million, profits of $13 million, and revenue of $27 million, with 196 employees.

more
Strongest Rank Dividend Yield
Weakest Rank Capital Growth
Country USA
Industry Health Care Technology
Size Small
Website shop.mydario.com
Index
NASDAQ
DarioHealth stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
58 76 53 47
Growth
63 32 29 45
Safety
Safety
65 65 65 58
Sentiment
17 14 35 69
360° View
360° View
29 29 32 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
76 70 77 63
Opinions Change
50 23 50 50
Pro Holdings
n/a 4 18 18
Market Pulse
2 49 34 90
Sentiment
17 14 35 69
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
58 76 53 47
Growth
63 32 29 45
Safety Safety
65 65 65 58
Combined
35 35 41 74
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
53 91 58 32
Price vs. Earnings (P/E)
34 34 34 34
Price vs. Book (P/B)
92 97 88 84
Dividend Yield
1 1 1 1
Value
58 76 53 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
79 90 82 88
Profit Growth
6 77 45 4
Capital Growth
98 1 21 98
Stock Returns
47 1 15 7
Growth
63 32 29 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
34 56 58 100
Refinancing
90 87 93 88
Liquidity
8 8 12 17
Safety Safety
65 65 65 58

Similar Stocks

Discover high‑ranked alternatives to DarioHealth and broaden your portfolio horizons.

Salesforce

NYQ:CRM
Country: USA
Industry: Application Software
Size: XX-Large
Full Stock Analysis

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Walt Disney

NYQ:DIS
Country: USA
Industry: Movies & Entertainment
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NSQ:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The company has high growth and safe financing but is expensive (low Value Rank) and has low market sentiment. This is a warning that the stock may be too expensive. This is for an experienced growth investor willing to risk overpaying, but only after conducting thorough research on future growth potential.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews